Delivery Order SPE2DP23D0003-SPE2DP23F2634
- Not listed
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
- This contract award is for the delivery of Influenza Virus Vaccine to the U.S. government. The contract was awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production and medical supplies. The contract has a ceiling value of $3,472.00 and a performance period through September 26, 2025. It is a firm fixed-price Delivery Order contract awarded by the Medical Supply Chain, which is an alternate name for the Defense federal agency. The...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This is a delivery order awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by a U.S. government agency. The $1,428,430.40 firm fixed-price contract is for the delivery of influenza virus vaccines. The performance period is from the award date of July 3, 2025 through the ultimate completion date of September 26, 2025. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various federal agencies, including the Centers for Disease...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of vaccines and pharmaceuticals, for the production and delivery of influenza virus vaccines. The award, valued at $559,592.55, was made by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed price basis without any set-aside designation. The contract has an ultimate completion date of March 31, 2025. Sanofi Pasteur Inc. is an experienced government contractor, holding several...
- This firm fixed price purchase order was awarded to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical products, to provide influenza virus vaccines to the Medical Supply Chain, a component of the Defense Logistics Agency. The $1,548.18 contract has a completion date of September 30, 2024 and is not associated with any set-aside designation. Sanofi Pasteur Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $3,893,798.40, is for the delivery of influenza virus vaccines. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency to Sanofi Pasteur Inc. for the delivery of influenza virus vaccines. The award, valued at $55,978.87, is a firm fixed price delivery order contract with an ultimate completion date of April 19, 2024. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods that has previously received awards from various federal agencies to supply vaccines and...
- This is a $87,130.68 firm fixed price purchase order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc. for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 29, 2021 and does not have a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, and medical supplies to federal agencies. The company holds several indefinite delivery vehicles (IDVs) with agencies...
- SPE2DP23D0003Indefinite Delivery Contract
- SPE2DP23D0003-SPE2DP23F2634Delivery Order
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various U.S. federal agencies, including the Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs, and Department of Health and Human Services. The company holds multiple significant Indefinite Delivery Contracts (IDVs) with these agencies for the procurement of adult and pediatric vaccines, supporting critical public health initiatives across federal, state, and tribal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2m | 3/8/23 |